Market IntelligenceSensex Adds 136 Points, Nifty Ends Above 25,100 Amid Weekly F&O ExpiryBY Outlook Money
InvestSun Pharma Share Price Down 4%, Nifty Pharma Extends Losing Streak Amid Trump's Tariff Announcement - Know What Investors Should DoBY Ayush Khar
InvestNifty Pharma Extends Winning Streak For 5th Straight Session Even As Trump Tariffs Trample D-StreetBY Rishabh Raj
InvestNifty Pharma Struggles To Scale New High, Remains Range-Bound Since April: Reasons Behind StagnationBY Rishabh Raj
InvestPharma Stocks Gain Up To 5.50 Per Cent As US Outlines Plan To Lower Drug PricesBY Outlook Money
InvestTrump’s Tariff Pause: Domestic Pharma Stocks Gain Up To 7 Per Cent, Nifty Pharma Surges 3 Per CentBY Outlook Money
InvestMankind, Torrent Dodge Trump's Tariff Torpedo Even As Pharma Index Declines 3 Per Cent In Five Sessions, Know WhyBY Ayush Khar
InvestNifty Pharma Shares Trade In Green After Getting Respite From Trump’s Reciprocal TariffsBY Outlook Money
InvestTrump's 26 Per Cent Tariff On India Triggers Sell-Off In Sensex And Nifty: IT Worst Hit, Pharma Top Sectoral GainerBY Outlook Money
InvestNifty Pharma In Red, Dr Reddy, Lupin, Aurobindo, Sun Pharma Down Up To 3 Per Cent; Here’s WhyBY Outlook Money
NewsKeep Faith On IT, Pharma, Banking Stocks: HDFC AMC’s Prashant Jain Advises InvestorsBY Outlook Money
